BlackRock, Inc. 13D and 13G filings for EyePoint Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | BlackRock Inc. BLK | 4,155,158 7.800% | 0 (Unchanged) | Filing |
| 2024-10-22 3:24 pm Purchase | 2024-09-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | BlackRock Inc. BLK | 4,155,158 7.800% | 4,155,158 (New Position) | Filing |